These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20505893)

  • 1. Physical aspects of scintigraphy-based dosimetry for nuclear medicine therapy.
    Geworski L; Schaefer A; Knoop BO; Pinkert J; Plotkin M; Kirsch CM
    Nuklearmedizin; 2010; 49(3):85-95. PubMed ID: 20505893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TestDose: A nuclear medicine software based on Monte Carlo modeling for generating gamma camera acquisitions and dosimetry.
    Garcia MP; Villoing D; McKay E; Ferrer L; Cremonesi M; Botta F; Ferrari M; Bardiès M
    Med Phys; 2015 Dec; 42(12):6885-94. PubMed ID: 26632045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT Applied for Dosimetry of Radiopharmaceutical Therapy.
    Ljungberg M; Celler A; Konijnenberg MW; Eckerman KF; Dewaraja YK; Sjögreen-Gleisner K; ; Bolch WE; Brill AB; Fahey F; Fisher DR; Hobbs R; Howell RW; Meredith RF; Sgouros G; Zanzonico P; ; Bacher K; Chiesa C; Flux G; Lassmann M; Strigari L; Walrand S
    J Nucl Med; 2016 Jan; 57(1):151-62. PubMed ID: 26471692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessments for high dose radionuclide therapy treatment planning.
    Fisher DR
    Radiat Prot Dosimetry; 2003; 105(1-4):581-6. PubMed ID: 14527031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates.
    Siegel JA; Thomas SR; Stubbs JB; Stabin MG; Hays MT; Koral KF; Robertson JS; Howell RW; Wessels BW; Fisher DR; Weber DA; Brill AB
    J Nucl Med; 1999 Feb; 40(2):37S-61S. PubMed ID: 10025848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow dosimetry using blood-based models for radiolabeled antibody therapy: a multiinstitutional comparison.
    Wessels BW; Bolch WE; Bouchet LG; Breitz HB; Denardo GL; Meredith RF; Stabin MG; Sgouros G;
    J Nucl Med; 2004 Oct; 45(10):1725-33. PubMed ID: 15471841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A quality-control method for SPECT-based dosimetry in targeted radionuclide therapy.
    Gear JI; Charles-Edwards E; Partridge M; Flux GD
    Cancer Biother Radiopharm; 2007 Feb; 22(1):166-74. PubMed ID: 17627426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extension of the biological effective dose to the MIRD schema and possible implications in radionuclide therapy dosimetry.
    Baechler S; Hobbs RF; Prideaux AR; Wahl RL; Sgouros G
    Med Phys; 2008 Mar; 35(3):1123-34. PubMed ID: 18404947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation dosimetry in nuclear medicine.
    Stabin MG; Tagesson M; Thomas SR; Ljungberg M; Strand SE
    Appl Radiat Isot; 1999 Jan; 50(1):73-87. PubMed ID: 10028629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioimmunotherapy dosimetry--a review.
    Strand SE; Jönsson BA; Ljungberg M; Tennvall J
    Acta Oncol; 1993; 32(7-8):807-17. PubMed ID: 8305230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive dose reconstruction methodology for former rocketdyne/atomics international radiation workers.
    Boice JD; Leggett RW; Ellis ED; Wallace PW; Mumma M; Cohen SS; Brill AB; Chadda B; Boecker BB; Yoder RC; Eckerman KF
    Health Phys; 2006 May; 90(5):409-30. PubMed ID: 16607174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET/CT-derived whole-body and bone marrow dosimetry of 89Zr-cetuximab.
    Makris NE; Boellaard R; van Lingen A; Lammertsma AA; van Dongen GA; Verheul HM; Menke CW; Huisman MC
    J Nucl Med; 2015 Feb; 56(2):249-54. PubMed ID: 25613538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A stylized computational model of the rat for organ dosimetry in support of preclinical evaluations of peptide receptor radionuclide therapy with (90)Y, (111)In, or (177)Lu.
    Konijnenberg MW; Bijster M; Krenning EP; De Jong M
    J Nucl Med; 2004 Jul; 45(7):1260-9. PubMed ID: 15235075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EANM Dosimetry Committee guidelines for bone marrow and whole-body dosimetry.
    Hindorf C; Glatting G; Chiesa C; Lindén O; Flux G;
    Eur J Nucl Med Mol Imaging; 2010 Jun; 37(6):1238-50. PubMed ID: 20411259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimizing and communicating radiation risk in pediatric nuclear medicine.
    Fahey FH; Treves ST; Adelstein SJ
    J Nucl Med; 2011 Aug; 52(8):1240-51. PubMed ID: 21764783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation and evaluation of patient-specific three-dimensional internal dosimetry.
    Kolbert KS; Sgouros G; Scott AM; Bronstein JE; Malane RA; Zhang J; Kalaigian H; McNamara S; Schwartz L; Larson SM
    J Nucl Med; 1997 Feb; 38(2):301-8. PubMed ID: 9025759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MIRD pamphlet No. 23: quantitative SPECT for patient-specific 3-dimensional dosimetry in internal radionuclide therapy.
    Dewaraja YK; Frey EC; Sgouros G; Brill AB; Roberson P; Zanzonico PB; Ljungberg M
    J Nucl Med; 2012 Aug; 53(8):1310-25. PubMed ID: 22743252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight-based, low-dose pediatric whole-body PET/CT protocols.
    Alessio AM; Kinahan PE; Manchanda V; Ghioni V; Aldape L; Parisi MT
    J Nucl Med; 2009 Oct; 50(10):1570-7. PubMed ID: 19793734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation dosimetry for radionuclide therapy in a nonmyeloablative strategy.
    DeNardo GL; Siantar CL; DeNardo SJ
    Cancer Biother Radiopharm; 2002 Feb; 17(1):107-18. PubMed ID: 11915167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodistribution and dosimetry of 195mPt-cisplatin in normal volunteers. Imaging agent for single photon emission computed tomography.
    Sathekge M; Wagener J; Smith SV; Soni N; Marjanovic-Painter B; Zinn C; Van de Wiele C; D'Asseler Y; Perkins G; Zeevaart JR
    Nuklearmedizin; 2013 Dec; 52(6):222-7. PubMed ID: 24108524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.